Terms ending in 2035
Every in-force patent on 3-D Matrix, Ltd.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,654,893 | Self-Assembling Peptide Compositions In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 10,369,237 | Sterilization and Filtration of Peptide Compositions In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 12,115,264 | Sterilization and Filtration of Peptide Compositions In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 10,286,200 | Syringe and Syringe Set In force · High confidence | Taisei Kako Co., Ltd., Fuso Pharmaceutical Industries, Ltd. and 3-D Matrix, Ltd. | In force | High confidence | |
| US 10,596,265 | Synthesis of Nano Aggregate of Chitosan Modified by Self-Assembling Peptide and Application Thereof to Protein Delivery In force · High confidence | Tokyo University of Science Foundation and 3-D Matrix, Ltd. | In force | High confidence | |
| US 11,090,398 | Sterilization and Filtration of Peptide Compositions In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 10,682,441 | Self-Assembling Peptides Comprising Non-Ionic Polar Amino Acids In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 11,497,833 | Self-Assembling Peptides Comprising Non-Ionic Polar Amino Acids In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.